Clinical Trials Arena is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More X
X

Lorcaserin, Investigational Oral Anti-Obesity Drug

Drug

Lorcaserin

Company/Licensee

Arena Pharmaceuticals

Patentee

Arena Pharmaceuticals (US & Europe)

Therapy Class

Bariatrics

Product Description

Investigative treatment for obesity

Current Indication

Selective agonist of 5-HT<span class="sub">2c</span> serotonin receptors

Market Sector

Anti-obesity drugs

Development Status

Pre-approval (US)

Dosage Forms

Oral
Expand
Close
Close
Close

Go Top